People Nicole Blijlevens

Profile

prof. dr. Nicole Blijlevens
BIG-number: 79025920201


About Nicole Blijlevens

Research focus of Prof. dr. Nicole Blijlevens is on personalized supportive care to reduce side effects of cancer therapy for patients with hematological diseases and to improve their integrated care. read more

About Nicole Blijlevens

Research focus of Prof. dr. Nicole Blijlevens is on personalized supportive care to reduce side effects of cancer therapy for patients with hematological diseases and to improve their integrated care. Nicole Blijlevens is an MD, PhD in internal medicine (subspecialty Hematology) and head of the department of hematology (Radboudumc). lnternational activities of Prof. dr. N. Blijlevens include being a certified clinical inspector for the JACIE SCT accreditation program, and membership of the Complications and Quality of life Working Party of the EBMT, membership of the lnfectious diseases group of the EORTC, ICHS and ECIL and of the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer (MASCC) and of the Oral Care Study Group of the MASCC/ISOO. She is author of several international guidelines, chapters in textbooks and peer-reviewed articles in the field of supportive care. Her national activities include Secretary of Executive Board of the Dutch Society of Hematology (NVvH), Chair Commission Quality of NVvH, Chair Commission of Organization and Finance of NVvH and HOVON, Chair of Supportive Care Working Party of HOVON and Chair Commission Evaluation of Effects and Costs (EEK) of Doelmatigheidsprogramma ZonMW including Member of the Commission DoelmatigheidsOnderzoek ZonMw.

Position(s)

  • internist hematoloog/afdelingshoofd

Additional Functions

  • Initiator and founder of CMyLife
  • Chair of the Hematology working group of the Horizon Scan Medicines Healthcare Institute of the Netherlands
  • Chair of the NVvH Healthcare Innovation Committee
read more

Additional Functions

  • Initiator and founder of CMyLife
  • Chair of the Hematology working group of the Horizon Scan Medicines Healthcare Institute of the Netherlands
  • Chair of the NVvH Healthcare Innovation Committee
  • Member of the task group for indication-wide approach to MM (multiple myeloma), led by the Zorginstituut Nederland
  • Member of lnfectious diseases group of the EORTC, ICHS, ECIL, Mucositis Study Group of the Multinational Association of Supportive Care in Cancer (MASCC) and Oral Care Study Group of the MASCC/ISOO
  • Member of group RHONDA: Real-time Hemato-ONcology Dashboard
  • Member of the Expensive Medicines Committee NVvH
  • Former Chair NVvH
  • Former Treasurer HOVON
  • Former member of the Supervisory Board Matchis

Social media


Research position

  • (junior) principal investigator